From Genomic Tests to AI Predictions: Dr. Amrie Grammer, Co-Founder of Ampel BioSolutions, Joins BioTalk
Listen now
Description
Can you envision a world where precision medicine transforms healthcare as we know it? Tune in to this exciting episode of BioTalk with Rich Bendis, featuring Dr. Amrie Grammer, Co-Founder of Ampel BioSolutions. In this enlightening discussion, Dr. Grammer unveils the secrets behind Ampel's remarkable success in precision medicine, making this episode a must-listen. Learn about the groundbreaking genomic tests developed by Ampel, providing decision support for autoimmune diseases, and delve into the role of artificial intelligence in predicting potential treatments. Explore the immense potential for a revolution in healthcare as Dr. Grammer shares insights on understanding the human genome and Ampel's cutting-edge work in harnessing Big Data and Machine Learning for personalized precision medicine. Don't miss this great episode and gain valuable insights into the future of data-driven health.
More Episodes
Join us in this episode of BioTalk with Rich Bendis as we delve into the Baltimore ecosystem with Kory Bailey, Chief Ecosystem Officer (CEO) of UpSurge Baltimore, a trailblazing organization dedicated to fostering equitable economic growth and innovation. Kory Bailey brings over a decade of...
Published 03/24/24
Published 03/24/24
Discover the Future of Healthcare with John Sackett, Executive Vice President & COO of Adventist Healthcare, on BioTalk with Rich Bendis. In this episode, John Sackett shares his insights into the changing landscape of healthcare delivery. From his early days as an administrative assistant...
Published 03/18/24